CKNT.F Stock Overview
Cell Kinetics Ltd. engages in the refining and commercialization of CellScan and related technology.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cell Kinetics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | -99.77% |
| 5 Year Change | -83.33% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| CKNT.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | 0.08% | 0.3% |
| 1Y | n/a | 1.1% | 24.2% |
Return vs Industry: Insufficient data to determine how CKNT.F performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how CKNT.F performed against the US Market.
Price Volatility
| CKNT.F volatility | |
|---|---|
| CKNT.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CKNT.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CKNT.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | n/a | n/a |
Cell Kinetics Ltd. engages in the refining and commercialization of CellScan and related technology. It focuses on the development and commercialization of a cell carrier technology known as CKChip, a platform static cytometry technology that enables the simultaneous examination of various individual live cells using simple imaging methods, such as fluorescence microscopy. The company was founded in 1992 and is headquartered in Lod, Israel.
Cell Kinetics Ltd. Fundamentals Summary
| CKNT.F fundamental statistics | |
|---|---|
| Market cap | US$2.00k |
| Earnings (TTM) | -US$2.38m |
| Revenue (TTM) | US$21.00k |
0.0x
P/S Ratio0.0x
P/E RatioIs CKNT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CKNT.F income statement (TTM) | |
|---|---|
| Revenue | US$21.00k |
| Cost of Revenue | US$14.00k |
| Gross Profit | US$7.00k |
| Other Expenses | US$2.39m |
| Earnings | -US$2.38m |
Last Reported Earnings
Dec 31, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CKNT.F perform over the long term?
See historical performance and comparison